Fergens Duvalsaint in Jamaica, New York

Home New York Jamaica

Fergens Duvalsaint has Anesthesiology as his primary medical specialty. Their primary office is: 8900 Van Wyck Expy in Jamaica, New York.

They're a part of the: Jamaica Anesthesiologist Pc medical group which has around 53 members. You can call their office at 718-206-6088 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1980 (around 44 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Fergens G Duvalsaint Office Phone and Directions

Fergens Duvalsaint
Jamaica Anesthesiologist Pc
8900 Van Wyck Expy
Jamaica, New York 11418
718-206-6088

Patient Ratings
Please rate your experience with Fergens Duvalsaint below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 718-206-6088

Enter a starting address:

Healthcare Info for Fergens Duvalsaint

Additional Medical Specialties Include:
PAIN MANAGEMENT

Medical School: Sorry, his university is not listed
Graduation Year: 1980
The Primary Medical Specialty for Fergens Duvalsaint is listed as: Anesthesiology
Approximate Years of Experience: 44
PAC (PECOS ID)#: 5092807172
NPI #: 1184655664
NPI Created On: 07/05/2006
NPI Last Updated Listed as: 03/05/2013
Primary Taxonomy Code: 207L00000X
License Number:
171413
Listed Gender: Male

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 849465339

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Pain Management

Name of Drug #1: Exparel

Open Associated Drug #1: 65250-266-09